In a recent study published in the journal Nature Medicine, an international team of researchers evaluated the efficacy, safety, and tolerability of extended-release ketamine tablets (R-107) in adult ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Credit: FDA. The letter states that the application cannot be approved in its present form. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Incyte regarding the ...
Granules India arm gets USFDA tentative nod for generic ADHD tablets with 180-day exclusivity eligibility, expanding its ...
AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...
Children and adults with Prader-Willi syndrome who previously received once-daily diazoxide choline extended-release tablets ...
HYDERABAD, India &PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ...
Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback